Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Bacterial Expression and Immune Response in the Severity of Pertussis

NCT05897879 is registered in ClinicalTrials.gov with Institut Pasteur as lead sponsor.

NCT NCT05897879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05897879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Bacterial Expression and Immune Response in the Severity of Pertussis
Lead sponsor
Institut Pasteur
Phase
Not applicable
Overall status
Recruiting
Start date
November 16, 2023
Completion date
November 16, 2026
Enrollment
210 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

bordetella pertussis, whooping cough